COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,785 Articles (22,523 medRxiv, 8,262 bioRxiv)

Most recent first Previous |  Page 2509: Articles 25081-25090  | Next

Does Biological Therapy Protect against Severe COVID-19?
Mazzucchelli, R., Almodovar-Gonzalez, R., Crespi-Villarias, N., Garcia-Zamora, E., Perez-Fernandez, E., Quiros-Donate, J., Perez-Encinas, M., Sanmartin-Fenollera, P., Velasco-Arribas, M., Lopez-Serrano, P., Perez-Calle, J. l., Fernandez-Rodriguez, C., Lopez-Estebaranz, J. L., Zarco-Montejo, P.
10.1101/2020.06.21.20136788 — Posted: 2020-06-24 Discussion: Onsite
Knowledge about COVID-19 and patients beliefs about and use of herbal products during the COVID-19 pandemic: a cross-sectional study in Saudi Arabia
Alyami, H. S., Orabi, M. A. A., Aldhabbah, F. M., Alturki, H. N., Aburas, W. I., Alfayez, A. I., Alharbi, A. S., Almasuood, R. A., Alsuhaibani, N. A.
10.1101/2020.06.23.20138107 — Posted: 2020-06-24
An agent based modelling approach to study lockdown efficacy for infectious disease spreads
Pathak, A., Madan Mohan, V., Banerjee, A.
10.1101/2020.06.22.20137828 — Posted: 2020-06-24
Analysis and Prediction of COVID-19 Characteristics Using a Birth-and-Death Model
Viswanath, N. C.
10.1101/2020.06.23.20138719 — Posted: 2020-06-24
Forecasting COVID-19 and Analyzing the Effect of Government Interventions
Li, M. L., Tazi Bouardi, H., Skali Lami, O., Trikalinos, T. A., Trichakis, N. K., Bertsimas, D.
10.1101/2020.06.23.20138693 — Posted: 2020-06-24
Seroprevalence of SARS-CoV-2 IgG significantly varies with age: results from a mass population screening (SARS-2-SCREEN-CdA).
Pagani, G., Conti, F., Giacomelli, A., Bernacchia, D., Rondanin, R., Prina, A., Scolari, V., Gandolfi, C. E., Castaldi, S., Marano, G., Ottomano, C., Boracchi, P., Biganzoli, E. M., Galli, M.
10.1101/2020.06.24.20138875 — Posted: 2020-06-24 Discussion: Onsite
A model of COVID-19 transmission and control on university campuses
Lopman, B., Liu, C., Le Guillou, A., Lash, T. L., Isakov, A., Jenness, S.
10.1101/2020.06.23.20138677 — Posted: 2020-06-24
Only a combination of social distancing and massive testing can effectively stop COVID-19 progression in densely populated urban areas
Alvarez, M. M., Trujillo-de Santiago, G.
10.1101/2020.06.23.20138743 — Posted: 2020-06-24 Discussion: Onsite
Initial experience with short-course corticosteroids in a small cohort of adults with severe COVID-19 in a tertiary care hospital in India
Jha, S., Shetty, K., Vadi, S., Phadtare, S., Raut, A., Shah, S., Bhargava, P., Singhal, T.
10.1101/2020.06.23.20137471 — Posted: 2020-06-24
Longitudinal immunological analyses reveal inflammatory misfiring in severe COVID-19 patients
Lucas, C., Wong, P., Klein, J., Castro, T., Silva, J., Sundaram, M., Ellingson, M., Mao, T., Oh, J., Israelow, B., Tokuyama, M., Lu, P., Venkataraman, A., Park, A., Mohanty, S., Wang, H., Wyllie, A. L., Vogels, C. B. F., Earnest, R., Lapidus, S., Ott, I., Moore, A., Muenker, C., Fournier, J., Campbell, M., Odio, C., Casanovas-Massana, A., Yale IMPACT Team, , Herbst, R., Shaw, A., Medzhitov, R., Schulz, W. L., Grubaugh, N., Dela Cruz, C., Farhadian, S., Ko, A., Omer, S., Iwasaki, A.
10.1101/2020.06.23.20138289 — Posted: 2020-06-24 Discussion: Onsite | Offsite

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).